The National Pharmaceutical Pricing Authority (NPPA) has increased the ceiling prices of eight essential drugs by 50%, citing rising production costs and concerns over drug availability. The move aims to ensure the continued production and accessibility of these crucial medications for conditions like asthma, glaucoma, and tuberculosis.